1-4 of 4
Céline Callens, PharmD, PhD
Close
Sort by
Journal Articles

Phase 2 Trial of Single Agent Gedatolisib (PF-05212384), a Dual PI3K/mTOR Inhibitor, for Adverse Prognosis and Relapse/Refractory AML: Clinical and Transcriptomic Results

Jacques Vargaftig, MD PhD, Hassan Farhat, MD, Lionel Ades, MD PhD, Adrien Briaux, Camille Benoist, Isabelle Turbiez, Norbert Vey, MD PhD, Sylvie Glaisner, MD, Céline Callens, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5233.
https://doi.org/10.1182/blood-2018-99-117485
Published: 2018
Journal Articles

Ferric Carboxymaltose Alone or Combined with Erythropoietin Allows a Modest Increase in Hemoglobin for the Treatment of Cancer-Related Anemia in Advanced Cancer Patients

Cécile Blanc, Marie-Eglantine Dujaric, Caroline Giard, PharmD, Bernard Asselain, MD PhD, Isabelle Ferry, PharmD, Sylvie Glaisner, MD, Céline Callens, PharmD, PhD, Jacques Vargaftig, MD
Journal: Blood
Blood (2014) 124 (21): 4884.
https://doi.org/10.1182/blood.V124.21.4884.4884
Published: 2014
Journal Articles

Association of Deferasirox and Vitamin D Promotes Cell Differentiation and Improves Overall Survival in Acute Myeloid Leukemia (AML) Elderly Patients After Demethylating Agents Failure: A Retrospective Case Control Study

Etienne Paubelle, Felipe Suarez, MD, PhD, Florence Zylbersztejn, Celine Callens, PharmD PhD, Michael Dussiot, Marc Benhamou, Françoise Isnard, MD, Marie T Rubio, MD, PhD, Gandhi Damaj, Norbert C. Gorin, MD, PhD, Jean-Pierre Marolleau, MD, PhD, Ivan Cruz Moura, PhD, Olivier Hermine
Journal: Blood
Blood (2012) 120 (21): 3622.
https://doi.org/10.1182/blood.V120.21.3622.3622
Published: 2012
Journal Articles

Polymeric Immunoglobulin A1 Controls Erythroblast Proliferation and Accelerates Erythropoiesis Recovery in Anemia

Séverine Coulon, PharmD PhD, Michael Dussiot, Damien Grapton, Thiago Maciel, PhD, Pamella Huey Mei Wang, PhD, Celine Callens, PharmD PhD, Bertrand Arnulf, MD, PhD, Patrick Mayeux, Benhamou Marc, Michel Cogné, MD, PhD, Renato Monteiro, MD, PhD, Olivier Hermine, MD, PhD, Ivan Cruz Moura, PhD
Journal: Blood
Blood (2011) 118 (21): 679.
https://doi.org/10.1182/blood.V118.21.679.679
Published: 2011